Daniel Kemp Email

CEO . Shinobi Therapeutics

San Francisco, CA

Location

Current Roles

Employees:
38
Revenue:
$7.1M
About
Shinobi Therapeutics is developing a new class of hypoimmune CD8ab iPS-T cells for cancer and beyond by using immune evasion to unlock the full potential of iPSCs.\n \n\n \n \n Show more\n \n\n \n\n\n \n \n Show less
Shinobi Therapeutics Address

San Francisco, CA
United States
Shinobi Therapeutics Email